GB812366A
(en)
|
1955-08-18 |
1959-04-22 |
Wellcome Found |
Improvements in and relating to derivatives of pyrimidine and the preparation thereof
|
GB937725A
(en)
|
1960-05-11 |
1963-09-25 |
Ciba Ltd |
Pyrazolo[3:4-d]pyrimidines
|
DE2004713A1
(de)
|
1970-02-03 |
1971-08-12 |
Boehnnger Mannheim GmbH, 6800 Mann heim Waldhof |
Nitrofuryl triazolo pyrimidine und Verfahren zu ihrer Herstellung
|
US3657744A
(en)
|
1970-05-08 |
1972-04-25 |
Univ Minnesota |
Method for fixing prosthetic implants in a living body
|
IT1153216B
(it)
|
1981-10-16 |
1987-01-14 |
Schering Ag |
Procedimento per la preparazione di composti cianoeterociclici
|
DE3406533A1
(de)
|
1984-02-23 |
1985-08-29 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
|
US5310731A
(en)
*
|
1984-06-28 |
1994-05-10 |
Whitby Research, Inc. |
N-6 substituted-5'-(N-substitutedcarboxamido)adenosines as cardiac vasodilators and antihypertensive agents
|
JPS61109797A
(ja)
|
1984-11-01 |
1986-05-28 |
Yuki Gosei Yakuhin Kogyo Kk |
標識化ヌクレオチドおよび標識化ポリヌクレオチド
|
US4733665C2
(en)
|
1985-11-07 |
2002-01-29 |
Expandable Grafts Partnership |
Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
|
US5023252A
(en)
|
1985-12-04 |
1991-06-11 |
Conrex Pharmaceutical Corporation |
Transdermal and trans-membrane delivery of drugs
|
US5061273A
(en)
|
1989-06-01 |
1991-10-29 |
Yock Paul G |
Angioplasty apparatus facilitating rapid exchanges
|
US5040548A
(en)
|
1989-06-01 |
1991-08-20 |
Yock Paul G |
Angioplasty mehtod
|
US5350395A
(en)
|
1986-04-15 |
1994-09-27 |
Yock Paul G |
Angioplasty apparatus facilitating rapid exchanges
|
US4748982A
(en)
|
1987-01-06 |
1988-06-07 |
Advanced Cardiovascular Systems, Inc. |
Reinforced balloon dilatation catheter with slitted exchange sleeve and method
|
US5001139A
(en)
|
1987-06-12 |
1991-03-19 |
American Cyanamid Company |
Enchancers for the transdermal flux of nivadipine
|
US4992445A
(en)
|
1987-06-12 |
1991-02-12 |
American Cyanamid Co. |
Transdermal delivery of pharmaceuticals
|
WO1990003370A1
(en)
|
1988-09-28 |
1990-04-05 |
Microprobe Corporation |
DERIVATIVES OF PYRAZOLO[3,4-d]PYRIMIDINE
|
CA1322628C
(en)
|
1988-10-04 |
1993-10-05 |
Richard A. Schatz |
Expandable intraluminal graft
|
GB8827305D0
(en)
|
1988-11-23 |
1988-12-29 |
British Bio Technology |
Compounds
|
US5428125A
(en)
|
1989-07-17 |
1995-06-27 |
The Dow Chemical Company |
Mesogenic polycyanates and thermosets thereof
|
US5442039A
(en)
|
1989-07-17 |
1995-08-15 |
The Dow Chemical Company |
Mesogenic polycyanates and thermosets thereof
|
US6344053B1
(en)
|
1993-12-22 |
2002-02-05 |
Medtronic Ave, Inc. |
Endovascular support device and method
|
US5292331A
(en)
|
1989-08-24 |
1994-03-08 |
Applied Vascular Engineering, Inc. |
Endovascular support device
|
US5674278A
(en)
|
1989-08-24 |
1997-10-07 |
Arterial Vascular Engineering, Inc. |
Endovascular support device
|
US5763597A
(en)
|
1989-09-15 |
1998-06-09 |
Metabasis Therapeutics, Inc. |
Orally active adenosine kinase inhibitors
|
US5646128A
(en)
*
|
1989-09-15 |
1997-07-08 |
Gensia, Inc. |
Methods for treating adenosine kinase related conditions
|
US5721356A
(en)
|
1989-09-15 |
1998-02-24 |
Gensia, Inc. |
Orally active adenosine kinase inhibitors
|
US5674998A
(en)
|
1989-09-15 |
1997-10-07 |
Gensia Inc. |
C-4' modified adenosine kinase inhibitors
|
US5506347A
(en)
|
1993-02-03 |
1996-04-09 |
Gensia, Inc. |
Lyxofuranosyl analogues of adenosine
|
US5763596A
(en)
|
1989-09-15 |
1998-06-09 |
Metabasis Therapeutics, Inc. |
C-4' modified adenosine kinase inhibitors
|
US5795977A
(en)
|
1989-09-15 |
1998-08-18 |
Metabasis Therapeutics, Inc. |
Water soluble adenosine kinase inhibitors
|
GB9009542D0
(en)
|
1990-04-27 |
1990-06-20 |
Beecham Group Plc |
Novel compounds
|
GB9113137D0
(en)
|
1990-07-13 |
1991-08-07 |
Ici Plc |
Thioxo heterocycles
|
DE4026265A1
(de)
*
|
1990-08-20 |
1992-02-27 |
Boehringer Mannheim Gmbh |
Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel
|
US5563257A
(en)
|
1990-08-20 |
1996-10-08 |
Boehringer Mannheim Gmbh |
Phospholipid derivatives of nucleosides
|
US5652366A
(en)
|
1990-09-25 |
1997-07-29 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
DI (1R)-(-)camphosulfonic acid) salt, preparation thereof and use thereof
|
US5561134A
(en)
|
1990-09-25 |
1996-10-01 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
|
WO1992005177A1
(en)
|
1990-09-25 |
1992-04-02 |
Rhone-Poulenc Rorer International (Holdings) Inc. |
Compounds having antihypertensive and anti-ischemic properties
|
GB9103839D0
(en)
|
1991-02-23 |
1991-04-10 |
Smithkline Beecham Plc |
Pharmaceuticals
|
US5916891A
(en)
*
|
1992-01-13 |
1999-06-29 |
Smithkline Beecham Corporation |
Pyrimidinyl imidazoles
|
MX9300141A
(es)
|
1992-01-13 |
1994-07-29 |
Smithkline Beecham Corp |
Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
|
DE4204032A1
(de)
|
1992-02-12 |
1993-08-19 |
Boehringer Mannheim Gmbh |
Neue liponucleotide, deren herstellunmg sowie deren verwendung als antivirale arzneimittel
|
DE4204031A1
(de)
|
1992-02-12 |
1993-08-19 |
Boehringer Mannheim Gmbh |
Neue lipidphosphonsaeure-nucleosid-konjugate sowie deren verwendung als antivirale arzneimittel
|
WO1993018035A1
(en)
|
1992-03-04 |
1993-09-16 |
Abbott Laboratories |
Angiotensin ii receptor antagonists
|
GB9208135D0
(en)
|
1992-04-13 |
1992-05-27 |
Ludwig Inst Cancer Res |
Polypeptides having kinase activity,their preparation and use
|
CA2118513A1
(en)
|
1992-04-24 |
1993-11-11 |
David A. Zarling |
In vivo homologous sequence targeting in eukaryotic cells
|
JP3261617B2
(ja)
*
|
1992-06-19 |
2002-03-04 |
ハネウエル・インコーポレーテッド |
赤外線カメラ
|
US6057305A
(en)
|
1992-08-05 |
2000-05-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiretroviral enantiomeric nucleotide analogs
|
TW370529B
(en)
|
1992-12-17 |
1999-09-21 |
Pfizer |
Pyrazolopyrimidines
|
US5455258A
(en)
|
1993-01-06 |
1995-10-03 |
Ciba-Geigy Corporation |
Arylsulfonamido-substituted hydroxamic acids
|
IL108523A0
(en)
|
1993-02-03 |
1994-05-30 |
Gensia Inc |
Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain
|
AU6672794A
(en)
|
1993-11-05 |
1995-05-23 |
Biochem Pharma Inc. |
Antineoplastic heteronaphthoquinones
|
IL112249A
(en)
|
1994-01-25 |
2001-11-25 |
Warner Lambert Co |
Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
|
US5679683A
(en)
|
1994-01-25 |
1997-10-21 |
Warner-Lambert Company |
Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
|
US6632789B1
(en)
*
|
1994-04-29 |
2003-10-14 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for modulating T cell responses by manipulating intracellular signal transduction
|
DE4418690A1
(de)
|
1994-05-28 |
1996-01-11 |
Boehringer Mannheim Gmbh |
Neue Lipidester von Nucleosid-Monophosphaten und deren Verwendung als immunsuppressive Arzneimittel
|
US6323201B1
(en)
*
|
1994-12-29 |
2001-11-27 |
The Regents Of The University Of California |
Compounds for inhibition of ceramide-mediated signal transduction
|
US5863949A
(en)
|
1995-03-08 |
1999-01-26 |
Pfizer Inc |
Arylsulfonylamino hydroxamic acid derivatives
|
DE69609602T2
(de)
|
1995-04-03 |
2001-04-12 |
Novartis Ag |
Pyrazolderivate und verfahren zu deren herstellung
|
US6312894B1
(en)
|
1995-04-03 |
2001-11-06 |
Epoch Pharmaceuticals, Inc. |
Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
|
WO1996033172A1
(en)
|
1995-04-20 |
1996-10-24 |
Pfizer Inc. |
Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors
|
US5977061A
(en)
|
1995-04-21 |
1999-11-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
N6 - substituted nucleotide analagues and their use
|
US5593997A
(en)
*
|
1995-05-23 |
1997-01-14 |
Pfizer Inc. |
4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors
|
US6403599B1
(en)
|
1995-11-08 |
2002-06-11 |
Pfizer Inc |
Corticotropin releasing factor antagonists
|
WO1996040256A1
(en)
|
1995-06-07 |
1996-12-19 |
G.D. Searle & Co. |
Method to treat cardiofibrosis with a combination of an angiotensin ii antagonist and spironolactone
|
PT831910E
(pt)
|
1995-06-07 |
2002-05-31 |
Searle & Co |
Terapia de combinacao a base de um antagonista epoxi-esteroidal de aldosterona e um antagonista de angiotensina ii para o tratamento de ataque cardiaco congestivo
|
US5665721A
(en)
*
|
1995-06-07 |
1997-09-09 |
Abbott Laboratories |
Heterocyclic substituted cyclopentane compounds
|
EP0831911B1
(en)
|
1995-06-07 |
2002-04-17 |
G.D. Searle & Co. |
Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
|
US5763885A
(en)
|
1995-12-19 |
1998-06-09 |
Loral Infrared & Imaging Systems, Inc. |
Method and apparatus for thermal gradient stabilization of microbolometer focal plane arrays
|
GB9521987D0
(en)
|
1995-10-26 |
1996-01-03 |
Ludwig Inst Cancer Res |
Phosphoinositide 3-kinase modulators
|
EP0780386B1
(en)
|
1995-12-20 |
2002-10-02 |
F. Hoffmann-La Roche Ag |
Matrix metalloprotease inhibitors
|
US5747235A
(en)
|
1996-01-26 |
1998-05-05 |
Eastman Kodak Company |
Silver halide light sensitive emulsion layer having enhanced photographic sensitivity
|
CH690773A5
(de)
|
1996-02-01 |
2001-01-15 |
Novartis Ag |
Pyrrolo(2,3-d)pyrimide und ihre Verwendung.
|
DE19603576A1
(de)
|
1996-02-01 |
1997-08-07 |
Bayer Ag |
Acylierte 4-Amino und 4-Hydrazinopyrimidine
|
US5914488A
(en)
|
1996-03-05 |
1999-06-22 |
Mitsubishi Denki Kabushiki Kaisha |
Infrared detector
|
GB9611460D0
(en)
*
|
1996-06-01 |
1996-08-07 |
Ludwig Inst Cancer Res |
Novel lipid kinase
|
JP2000514048A
(ja)
|
1996-06-20 |
2000-10-24 |
ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム |
薬理学的活性調製物を提供するための化合物および方法ならびにそれらの使用
|
EP0923585B1
(en)
|
1996-07-18 |
2002-05-08 |
Pfizer Inc. |
Phosphinate based inhibitors of matrix metalloproteases
|
SK21499A3
(en)
|
1996-08-23 |
2000-05-16 |
Pfizer |
Arylsulfonylamino hydroxamic acid derivatives
|
DE69732780T2
(de)
|
1996-10-02 |
2006-04-06 |
Novartis Ag |
Pyrimiderivate und verfahren zu ihrer herstellung
|
US6251901B1
(en)
|
1996-10-23 |
2001-06-26 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
US5922753A
(en)
|
1996-10-23 |
1999-07-13 |
Zymogenetics, Inc. |
Methods for treating bone deficit conditions with benzothiazole
|
US5990169A
(en)
|
1996-10-23 |
1999-11-23 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
US5994358A
(en)
|
1996-10-23 |
1999-11-30 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
US6153631A
(en)
|
1996-10-23 |
2000-11-28 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
US5948776A
(en)
|
1996-10-23 |
1999-09-07 |
Zymogenetic, Inc. |
Compositions and methods for treating bone deficit conditions
|
US5919808A
(en)
|
1996-10-23 |
1999-07-06 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
US5965573A
(en)
|
1996-10-23 |
1999-10-12 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
US6342514B1
(en)
|
1996-10-23 |
2002-01-29 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
US5858753A
(en)
*
|
1996-11-25 |
1999-01-12 |
Icos Corporation |
Lipid kinase
|
DE69736984T2
(de)
*
|
1996-12-06 |
2007-09-13 |
Vertex Pharmaceuticals Inc., Cambridge |
Inhibitoren des interleukin-1-beta konvertierenden enzyms
|
US6093737A
(en)
|
1996-12-30 |
2000-07-25 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
BR9714266A
(pt)
|
1997-01-06 |
2000-04-18 |
Pfizer |
Derivados de sulfona cìclicos.
|
PL335027A1
(en)
|
1997-02-03 |
2000-03-27 |
Pfizer Prod Inc |
Derivatives of arylsulphonylamino hydroxamic acid
|
AU755062B2
(en)
*
|
1997-02-07 |
2002-12-05 |
Princeton University |
Engineered protein kinases which can utilize modified nucleotide triphosphate substrates
|
AU5493598A
(en)
|
1997-02-07 |
1998-08-26 |
Pfizer Inc. |
N-hydroxy-beta-sulfonyl-propionamide derivatives and their use as inhibitors of matrix metalloproteinases
|
AU722784B2
(en)
|
1997-02-11 |
2000-08-10 |
Pfizer Inc. |
Arylsulfonyl hydroxamic acid derivatives
|
DE69815317T2
(de)
|
1997-03-19 |
2005-04-07 |
Abbott Gmbh & Co. Kg |
Pyrrolo[2,3-d]pyrimidine und ihre verwendung als tyrosinkinase-inhibitoren
|
US7863444B2
(en)
*
|
1997-03-19 |
2011-01-04 |
Abbott Laboratories |
4-aminopyrrolopyrimidines as kinase inhibitors
|
AU6780398A
(en)
*
|
1997-03-28 |
1998-10-22 |
Du Pont Merck Pharmaceutical Company, The |
Heterocyclic integrin inhibitor prodrugs
|
EP0983768A1
(en)
|
1997-05-23 |
2000-03-08 |
Nippon Shinyaku Co., Ltd. |
Medicinal composition for prevention or treatment of hepatopathy
|
GB9711650D0
(en)
*
|
1997-06-05 |
1997-07-30 |
Pfizer Ltd |
Compounds useful in therapy
|
US6207679B1
(en)
|
1997-06-19 |
2001-03-27 |
Sepracor, Inc. |
Antimicrobial agents uses and compositions related thereto
|
EP1020445B1
(en)
|
1997-10-02 |
2008-08-13 |
Eisai R&D Management Co., Ltd. |
Fused pyridine derivatives
|
US6649631B1
(en)
|
1997-10-23 |
2003-11-18 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for treating bone deficit conditions
|
EP1043324B1
(en)
|
1997-11-12 |
2004-06-16 |
Mitsubishi Chemical Corporation |
Purine derivatives and medicine containing the same as the active ingredient
|
GB9725782D0
(en)
|
1997-12-05 |
1998-02-04 |
Pfizer Ltd |
Therapeutic agents
|
US6191170B1
(en)
|
1998-01-13 |
2001-02-20 |
Tularik Inc. |
Benzenesulfonamides and benzamides as therapeutic agents
|
GB9801690D0
(en)
|
1998-01-27 |
1998-03-25 |
Pfizer Ltd |
Therapeutic agents
|
US7715989B2
(en)
|
1998-04-03 |
2010-05-11 |
Elitech Holding B.V. |
Systems and methods for predicting oligonucleotide melting temperature (TmS)
|
US6127121A
(en)
|
1998-04-03 |
2000-10-03 |
Epoch Pharmaceuticals, Inc. |
Oligonucleotides containing pyrazolo[3,4-D]pyrimidines for hybridization and mismatch discrimination
|
PA8469401A1
(es)
|
1998-04-10 |
2000-05-24 |
Pfizer Prod Inc |
Derivados biciclicos del acido hidroxamico
|
PA8469501A1
(es)
|
1998-04-10 |
2000-09-29 |
Pfizer Prod Inc |
Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico
|
US6251689B1
(en)
|
1998-05-14 |
2001-06-26 |
Telik, Inc. |
Methods for the solid phase synthesis of combinatorial libraries of benzimidazoles benzoxazoles benzothiazoles and derivatives thereof
|
DZ2805A1
(fr)
*
|
1998-06-02 |
2005-01-30 |
Cadus Pharmaceutical Corp |
Composition à pyrroloÄ2,,3dÜ pyrimidine et leurs usages.
|
JP2000072773A
(ja)
|
1998-08-28 |
2000-03-07 |
Zeria Pharmaceut Co Ltd |
プリン誘導体
|
BR9913888A
(pt)
|
1998-09-18 |
2002-01-08 |
Basf Ag |
Composto, e, métodos de inibir a atividade da proteìna quinase, de tratar um paciente que tenha uma condição que seja mediada pela atividade da proteìna quinase e de diminuir a fertilidade em um paciente
|
US6713474B2
(en)
*
|
1998-09-18 |
2004-03-30 |
Abbott Gmbh & Co. Kg |
Pyrrolopyrimidines as therapeutic agents
|
EP1131319B1
(de)
*
|
1998-11-16 |
2003-09-03 |
Basf Aktiengesellschaft |
Herbizide 3-(benzo(ox/thi)azol-7-yl)-1h-pyrimidin-2,4-dione
|
US6319660B1
(en)
|
1998-12-28 |
2001-11-20 |
Eastman Kodak Company |
Color photographic element containing speed improving compound
|
AU779008C
(en)
|
1999-01-11 |
2005-06-30 |
Princeton University |
High affinity inhibitors for target validation and uses thereof
|
CZ27399A3
(cs)
*
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
EP1040831A3
(en)
|
1999-04-02 |
2003-05-02 |
Pfizer Products Inc. |
Use of corticotropin releasing factor (CRF) antagonists to prevent sudden death
|
SE515856C2
(sv)
*
|
1999-05-19 |
2001-10-22 |
Ericsson Telefon Ab L M |
Bärare för elektronikkomponenter
|
MXPA01012442A
(es)
|
1999-06-03 |
2004-09-10 |
Abbott Gmbh & Co Kg |
Compuestos de benzotiazinona y benzoxazinona.
|
US6387894B1
(en)
|
1999-06-11 |
2002-05-14 |
Pfizer Inc. |
Use of CRF antagonists and renin-angiotensin system inhibitors
|
TWI262914B
(en)
*
|
1999-07-02 |
2006-10-01 |
Agouron Pharma |
Compounds and pharmaceutical compositions for inhibiting protein kinases
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
GB9919588D0
(en)
|
1999-08-18 |
1999-10-20 |
Hoechst Schering Agrevo Gmbh |
Fungicidal compounds
|
WO2001016114A2
(en)
|
1999-08-27 |
2001-03-08 |
Chemocentryx, Inc. |
Heterocyclic compounds and methods for modulating cxcr3 function
|
AU780846B2
(en)
*
|
1999-09-16 |
2005-04-21 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
CZ2002936A3
(cs)
|
1999-09-17 |
2002-10-16 |
Abbott Gmbh & Co. Kg |
Pyrazolopyrimidiny jako terapeutické prostředky
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
US6506769B2
(en)
*
|
1999-10-06 |
2003-01-14 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Heterocyclic compounds useful as inhibitors of tyrosine kinases
|
MXPA02003364A
(es)
|
1999-10-06 |
2002-08-23 |
Boehringer Ingelheim Pharma |
Compuestos heterociclicos utiles como inhibidores de las cinasas de tirosina.
|
US6472153B1
(en)
|
1999-10-26 |
2002-10-29 |
Epoch Biosciences, Inc. |
Hybridization-triggered fluorescent detection of nucleic acids
|
US6660845B1
(en)
|
1999-11-23 |
2003-12-09 |
Epoch Biosciences, Inc. |
Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
|
GB0002032D0
(en)
|
2000-01-28 |
2000-03-22 |
Zeneca Ltd |
Chemical compounds
|
US7217722B2
(en)
|
2000-02-01 |
2007-05-15 |
Kirin Beer Kabushiki Kaisha |
Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
|
US6613798B1
(en)
|
2000-03-30 |
2003-09-02 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
US7115653B2
(en)
|
2000-03-30 |
2006-10-03 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
DE60144277D1
(de)
*
|
2000-04-25 |
2011-05-05 |
Icos Corp |
Hemmer der menschlichen phosphatidyl-inositol-3-kinase delta
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
US6777439B2
(en)
|
2000-05-30 |
2004-08-17 |
Advanced Research & Technology Institute, Inc. |
Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways
|
KR20030011371A
(ko)
*
|
2000-06-27 |
2003-02-07 |
진랩스 테크놀러지스, 인크. |
항세균, 항진균 또는 항암 활성을 갖는 신규 화합물
|
US6534691B2
(en)
|
2000-07-18 |
2003-03-18 |
E. I. Du Pont De Nemours And Company |
Manufacturing process for α-olefins
|
AU2002213467A8
(en)
*
|
2000-10-11 |
2009-07-30 |
Chemocentryx Inc |
Modulation of ccr4 function
|
WO2002030944A2
(en)
|
2000-10-11 |
2002-04-18 |
Applera Corporation |
Fluorescent nucleobase conjugates having anionic linkers
|
JP2002131859A
(ja)
|
2000-10-19 |
2002-05-09 |
Konica Corp |
撮影用赤外感光性ハロゲン化銀写真感光材料及び赤外感光性ハロゲン化銀乳剤
|
US6890747B2
(en)
*
|
2000-10-23 |
2005-05-10 |
Warner-Lambert Company |
Phosphoinositide 3-kinases
|
EA007538B1
(ru)
|
2000-12-11 |
2006-10-27 |
Туларик Инк. |
Антагонисты cxcr3
|
CA2430978C
(en)
*
|
2000-12-28 |
2012-05-15 |
Daiichi Pharmaceutical Co., Ltd. |
Vla-4 inhibitors
|
US7105499B2
(en)
|
2001-01-22 |
2006-09-12 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
EP1539188B1
(en)
*
|
2001-01-22 |
2015-01-07 |
Merck Sharp & Dohme Corp. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
MXPA03008560A
(es)
|
2001-03-22 |
2004-06-30 |
Abbot Gmbh & Co Kg |
Pirazolopirimidinas como agentes terapeuticos.
|
WO2002088025A1
(en)
|
2001-04-26 |
2002-11-07 |
New York University |
Method for dissolving carbon nanotubes
|
JP2004528376A
(ja)
|
2001-05-08 |
2004-09-16 |
クドス ファーマシューティカルズ リミテッド |
Parp阻害薬としてのイソキノリノン誘導体
|
WO2002094264A1
(en)
*
|
2001-05-23 |
2002-11-28 |
Tularik Inc. |
Ccr4 antagonists
|
US6777425B2
(en)
|
2001-06-13 |
2004-08-17 |
Genesoft Pharmaceuticals, Inc. |
Isoquinoline compounds having antiinfective activity
|
EP1470119A4
(en)
|
2001-06-13 |
2005-10-19 |
Genesoft Pharmaceuticals Inc |
BENZOTHIOPHENE COMPOUNDS WITH ANTI-INFECTIOUS ACTIVITY
|
WO2002101007A2
(en)
|
2001-06-13 |
2002-12-19 |
Genesoft Pharmaceuticals, Inc |
Antipathogenic benzamide compounds
|
WO2003000187A2
(en)
|
2001-06-21 |
2003-01-03 |
Ariad Pharmaceuticals, Inc. |
Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
EP1414443B1
(en)
*
|
2001-08-01 |
2006-11-15 |
Merck & Co., Inc. |
BENZIMIDAZO 4,5-f|ISOQUINOLINONE DERIVATIVES
|
AU2002327422A1
(en)
|
2001-08-03 |
2003-03-18 |
Abbott Laboratories |
Method of identifying inhibitors of lck
|
KR20100087209A
(ko)
|
2001-08-10 |
2010-08-03 |
시오노기세이야쿠가부시키가이샤 |
항바이러스제
|
JP2003073357A
(ja)
|
2001-09-03 |
2003-03-12 |
Mitsubishi Pharma Corp |
アミド化合物を含有するRhoキナーゼ阻害剤
|
WO2003024969A1
(en)
|
2001-09-14 |
2003-03-27 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
AU2002368274A1
(en)
|
2001-09-13 |
2004-06-03 |
Genesoft, Inc. |
Methods of treating infection by drug resistant bacteria
|
AUPR769501A0
(en)
*
|
2001-09-14 |
2001-10-11 |
Biomolecular Research Institute Limited |
Cytokine receptor 1
|
TWI330183B
(pt)
|
2001-10-22 |
2010-09-11 |
Eisai R&D Man Co Ltd |
|
AU2002343604C1
(en)
|
2001-10-30 |
2009-09-17 |
Conforma Therapeutics Corporation |
Purine analogs having HSP90-inhibiting activity
|
US7319858B2
(en)
|
2001-11-16 |
2008-01-15 |
Cingular Wireless Ii, Llc |
System and method for querying message information
|
AU2002350217A1
(en)
|
2001-12-04 |
2003-06-17 |
Bristol-Myers Squibb Company |
Glycinamides as factor xa inhibitors
|
JP5082033B2
(ja)
|
2001-12-21 |
2012-11-28 |
エグゼリクシス パテント カンパニー エルエルシー |
Lxrのモジュレーター
|
JP4085237B2
(ja)
|
2001-12-21 |
2008-05-14 |
日本電気株式会社 |
携帯電話の利用契約システムと通信方法
|
US7064218B2
(en)
|
2001-12-26 |
2006-06-20 |
Genelabs Technologies, Inc. |
Aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity
|
US7414036B2
(en)
|
2002-01-25 |
2008-08-19 |
Muscagen Limited |
Compounds useful as A3 adenosine receptor agonists
|
US20030225098A1
(en)
|
2002-03-21 |
2003-12-04 |
Hirst Gavin C. |
Kinase inhibitors
|
WO2003082341A1
(en)
|
2002-03-22 |
2003-10-09 |
Cellular Genomics, Inc. |
AN IMPROVED FORMULATION OF CERTAIN PYRAZOLO[3,4-d] PYRIMIDINES AS KINASE MODULATORS
|
WO2003080582A2
(de)
|
2002-03-26 |
2003-10-02 |
Biofrontera Discovery Gmbh |
Fredericamycin-derivate
|
US7166293B2
(en)
*
|
2002-03-29 |
2007-01-23 |
Carlsbad Technology, Inc. |
Angiogenesis inhibitors
|
DE10217046A1
(de)
|
2002-04-17 |
2003-11-06 |
Bioleads Gmbh |
Fredericamycin-Derivate
|
MXPA04010550A
(es)
|
2002-04-26 |
2005-01-25 |
Pfizer Prod Inc |
Inhibidores de metaloproteinasa de pirimidina-2,4,6-triona.
|
WO2004039774A2
(en)
|
2002-05-23 |
2004-05-13 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
CA2489367A1
(en)
|
2002-06-14 |
2003-12-24 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
KR101116627B1
(ko)
|
2002-06-27 |
2012-10-09 |
노보 노르디스크 에이/에스 |
치료제로서 아릴 카르보닐 유도체
|
US7265111B2
(en)
|
2002-06-27 |
2007-09-04 |
Sanofi-Aventis Deutschland Gmbh |
Adenosine analogues and their use as pharmaceutical agents
|
CN1678311A
(zh)
|
2002-06-27 |
2005-10-05 |
诺沃挪第克公司 |
用作治疗剂的芳基羰基衍生物
|
DE10230917A1
(de)
|
2002-07-09 |
2004-02-05 |
Bioleads Gmbh |
Fredericamycin-Derivate
|
WO2004006906A2
(en)
|
2002-07-15 |
2004-01-22 |
Combinatorx, Incorporated |
Methods for the treatment of neoplasms
|
WO2004014377A1
(en)
*
|
2002-08-13 |
2004-02-19 |
Warner-Lambert Company Llc |
4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors
|
JP4646626B2
(ja)
|
2002-08-16 |
2011-03-09 |
アストラゼネカ アクチボラグ |
ホスホイノシチド3−キナーゼβの阻害
|
JP2005536553A
(ja)
|
2002-08-21 |
2005-12-02 |
サイトキネティクス・インコーポレーテッド |
化合物、組成物および方法
|
US20030139427A1
(en)
|
2002-08-23 |
2003-07-24 |
Osi Pharmaceuticals Inc. |
Bicyclic pyrimidinyl derivatives and methods of use thereof
|
AU2003266668A1
(en)
|
2002-09-30 |
2004-04-23 |
Banyu Pharmaceutical Co., Ltd. |
2-aminobenzimidazole derivative
|
JP2004161716A
(ja)
|
2002-11-15 |
2004-06-10 |
Takeda Chem Ind Ltd |
Jnk阻害剤
|
UA80171C2
(en)
|
2002-12-19 |
2007-08-27 |
Pfizer Prod Inc |
Pyrrolopyrimidine derivatives
|
DE60335911D1
(de)
|
2002-12-20 |
2011-03-10 |
Daiichi Sankyo Co Ltd |
Isochinolinonderivate und deren verwendung als medikamente
|
US7247736B2
(en)
|
2002-12-23 |
2007-07-24 |
4Sc Ag |
Method of identifying inhibitors of DHODH
|
US7365094B2
(en)
|
2002-12-23 |
2008-04-29 |
4Sc Ag |
Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
|
WO2004056746A1
(en)
|
2002-12-23 |
2004-07-08 |
4Sc Ag |
Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
|
EP1599441A1
(en)
|
2003-03-06 |
2005-11-30 |
DSM IP Assets B.V. |
Process for the preparation of an alpha-amino carbonyl compound
|
JP4887139B2
(ja)
|
2003-03-25 |
2012-02-29 |
武田薬品工業株式会社 |
ジペプチジルペプチダーゼインヒビター
|
GB0306907D0
(en)
|
2003-03-26 |
2003-04-30 |
Angiogene Pharm Ltd |
Boireductively-activated prodrugs
|
US7217794B2
(en)
|
2003-04-02 |
2007-05-15 |
Daiamed, Inc. |
Compounds and methods for treatment of thrombosis
|
EP1646615B1
(en)
|
2003-06-06 |
2009-08-26 |
Vertex Pharmaceuticals Incorporated |
Pyrimidine derivatives as modulators of atp-binding cassette transporters
|
US7429596B2
(en)
*
|
2003-06-20 |
2008-09-30 |
The Regents Of The University Of California |
1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof
|
WO2005002585A1
(en)
|
2003-07-02 |
2005-01-13 |
Warner-Lambert Company Llc |
Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
|
BRPI0413005A
(pt)
|
2003-07-29 |
2006-09-26 |
Irm Llc |
compostos e composições como inibidores da proteìna cinase
|
GB0317951D0
(en)
|
2003-07-31 |
2003-09-03 |
Trigen Ltd |
Compounds
|
US7208601B2
(en)
|
2003-08-08 |
2007-04-24 |
Mjalli Adnan M M |
Aryl and heteroaryl compounds, compositions, and methods of use
|
WO2005014532A1
(en)
|
2003-08-08 |
2005-02-17 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds, compositions and methods of use
|
US20050043239A1
(en)
*
|
2003-08-14 |
2005-02-24 |
Jason Douangpanya |
Methods of inhibiting immune responses stimulated by an endogenous factor
|
US20050054614A1
(en)
*
|
2003-08-14 |
2005-03-10 |
Diacovo Thomas G. |
Methods of inhibiting leukocyte accumulation
|
CA2535620A1
(en)
|
2003-08-15 |
2005-02-24 |
Irm Llc |
6-substituted anilino purines as rtk inhibitors
|
US7390820B2
(en)
|
2003-08-25 |
2008-06-24 |
Amgen Inc. |
Substituted quinolinone derivatives and methods of use
|
WO2005044181A2
(en)
|
2003-09-09 |
2005-05-19 |
Temple University-Of The Commonwealth System Of Higher Education |
Protection of tissues and cells from cytotoxic effects of ionizing radiation by abl inhibitors
|
NZ546611A
(en)
|
2003-09-18 |
2010-02-26 |
Conforma Therapeutics Corp |
Novel heterocyclic compounds as HSP90-inhibitors
|
GB0322409D0
(en)
|
2003-09-25 |
2003-10-29 |
Astrazeneca Ab |
Quinazoline derivatives
|
AU2004279427B2
(en)
*
|
2003-10-08 |
2008-07-03 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
WO2005046698A1
(en)
|
2003-11-10 |
2005-05-26 |
Synta Pharmaceuticals, Corp. |
Fused heterocyclic compounds
|
JP2007511596A
(ja)
|
2003-11-17 |
2007-05-10 |
ファイザー・プロダクツ・インク |
癌の治療において有用なピロロピリミジン化合物
|
AR046845A1
(es)
|
2003-11-21 |
2005-12-28 |
Novartis Ag |
Derivados de 1h-imidazo[4,5-c]quinolina para tratamiento de enfermedades dependientes de las proteino-quinasas
|
WO2005061460A1
(en)
|
2003-12-08 |
2005-07-07 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
EP1715871A1
(en)
|
2003-12-22 |
2006-11-02 |
Gilead Sciences, Inc. |
Kinase inhibitor phosphonate conjugates
|
PL1699800T3
(pl)
|
2003-12-23 |
2010-07-30 |
Novartis Ag |
Bicykliczne heterocykliczne inhibitory kinazy p-38
|
CA2552664A1
(en)
|
2004-01-08 |
2005-07-28 |
Michigan State University |
Methods for treating and preventing hypertension and hypertension-related disorders
|
EP1730148A4
(en)
|
2004-02-03 |
2009-08-19 |
Abbott Lab |
USE OF AMINOBENZOXAZOLES AS THERAPEUTIC AGENTS
|
JP4102939B2
(ja)
*
|
2004-02-13 |
2008-06-18 |
萬有製薬株式会社 |
縮環4−オキソ−ピリミジン誘導体
|
US20050187418A1
(en)
|
2004-02-19 |
2005-08-25 |
Small Brooke L. |
Olefin oligomerization
|
EP1720874A4
(en)
|
2004-02-24 |
2010-03-03 |
Bioaxone Therapeutique Inc |
SUBSTITUTED PIPERIDINE DERIVATIVES IN POSITION 4
|
RU2006134021A
(ru)
|
2004-02-27 |
2008-04-10 |
Ф.Хоффманн-Ля Рош Аг (Ch) |
Производные гетероарил-конденсированного пиразола
|
AU2005219525B2
(en)
|
2004-02-27 |
2011-08-18 |
F. Hoffmann-La Roche Ag |
Fused derivatives of pyrazole
|
US20070293489A1
(en)
|
2004-04-02 |
2007-12-20 |
Jerry Adams |
Substituted Pyrazolopyrimidines
|
SG163576A1
(en)
|
2004-04-02 |
2010-08-30 |
Osi Pharm Inc |
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
|
AU2005238386A1
(en)
|
2004-04-30 |
2005-11-10 |
Takeda Pharmaceutical Company Limited |
Heterocyclic amide compound and use thereof as an MMP-13 inhibitor
|
DE102004022897A1
(de)
|
2004-05-10 |
2005-12-08 |
Bayer Cropscience Ag |
Azinyl-imidazoazine
|
EP1750714A1
(en)
|
2004-05-13 |
2007-02-14 |
Vanderbilt University |
Phosphoinositide 3-kinase delta selective inhibitors for inhibiting angiogenesis
|
CN101031569B
(zh)
*
|
2004-05-13 |
2011-06-22 |
艾科斯有限公司 |
作为人磷脂酰肌醇3-激酶δ抑制剂的喹唑啉酮
|
JP2008500338A
(ja)
|
2004-05-25 |
2008-01-10 |
イコス・コーポレイション |
造血細胞の異常増殖を治療及び/又は予防する方法
|
WO2005120511A1
(en)
|
2004-06-04 |
2005-12-22 |
Icos Corporation |
Methods for treating mast cell disorders
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
WO2006038865A1
(en)
|
2004-10-01 |
2006-04-13 |
Betagenon Ab |
Nucleotide derivatives for the treatment of type 2 diabetes and other disorders
|
US7622451B2
(en)
|
2004-11-03 |
2009-11-24 |
University Of Kansas |
Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
|
CA2585091C
(en)
|
2004-11-03 |
2016-07-19 |
University Of Kansas |
Novobiocin analogues as anticancer agents
|
US8212011B2
(en)
|
2004-11-03 |
2012-07-03 |
University Of Kansas |
Novobiocin analogues
|
US8212012B2
(en)
|
2004-11-03 |
2012-07-03 |
University Of Kansas |
Novobiocin analogues having modified sugar moieties
|
GB0425035D0
(en)
|
2004-11-12 |
2004-12-15 |
Novartis Ag |
Organic compounds
|
WO2006068760A2
(en)
|
2004-11-19 |
2006-06-29 |
The Regents Of The University Of California |
Anti-inflammatory pyrazolopyrimidines
|
EP1817025A2
(en)
|
2004-11-23 |
2007-08-15 |
PTC Therapeutics, Inc. |
Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control
|
DE602006016566D1
(de)
*
|
2005-01-10 |
2010-10-14 |
Bristol Myers Squibb Co |
Als antikoagulanzien verwendbare phenylglycinamid-derivate
|
US20060156485A1
(en)
|
2005-01-14 |
2006-07-20 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
PE20061119A1
(es)
*
|
2005-01-19 |
2006-11-27 |
Aventis Pharma Sa |
PIRAZOLO PIRIDINAS SUSTITUIDAS COMO INHIBIDORES DE CINASAS FAK, KDR Y Tie
|
GB0501999D0
(en)
*
|
2005-02-01 |
2005-03-09 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
US20080287469A1
(en)
|
2005-02-17 |
2008-11-20 |
Diacovo Thomas G |
Phosphoinositide 3-Kinase Inhibitors for Inhibiting Leukocyte Accumulation
|
US7579348B2
(en)
|
2005-02-25 |
2009-08-25 |
Pgxhealth, Llc |
Derivatives of 8-substituted xanthines
|
US20090124654A1
(en)
|
2005-03-01 |
2009-05-14 |
Mjalli Adnan M M |
Aryl and Heteroaryl Compounds, Compositions, Methods of Use
|
KR100926399B1
(ko)
|
2005-04-06 |
2009-11-12 |
아이알엠 엘엘씨 |
디아릴아민―함유 화합물 및 조성물, 및 스테로이드 호르몬핵 수용체의 조절제로서의 그들의 용도
|
KR100781704B1
(ko)
|
2005-04-20 |
2007-12-03 |
에스케이케미칼주식회사 |
피리딘 유도체와 이의 제조방법, 및 이를 포함하는약제조성물
|
CN101180283A
(zh)
|
2005-04-22 |
2008-05-14 |
惠氏公司 |
二氢苯并呋喃衍生物和其用途
|
WO2006114064A2
(en)
|
2005-04-25 |
2006-11-02 |
Institute Of Organic Chemistry And Biochemistry Ofthe Academy Of Sciences Of The Czech Republic |
Use of compounds to enhance processivity of telomerase
|
ZA200800309B
(en)
|
2005-06-22 |
2009-10-28 |
Chemocentryx Inc |
Azaindazole compounds and methods of use
|
DE602006015658D1
(de)
|
2005-06-27 |
2010-09-02 |
Amgen Inc |
Entzündungshemmende arylnitrilverbindungen
|
WO2007006547A1
(en)
|
2005-07-11 |
2007-01-18 |
Devgen N.V. |
Amide derivatives as kinase inhibitors
|
JP2009505948A
(ja)
|
2005-07-11 |
2009-02-12 |
デブジェン エヌブイ |
キナーゼ阻害剤としてのアミド誘導体
|
GB0516723D0
(en)
|
2005-08-15 |
2005-09-21 |
Novartis Ag |
Organic compounds
|
BRPI0615272A2
(pt)
|
2005-08-25 |
2009-08-04 |
Hoffmann La Roche |
inibidores de p38 map kinase e métodos para uso dos mesmos
|
US20070049591A1
(en)
|
2005-08-25 |
2007-03-01 |
Kalypsys, Inc. |
Inhibitors of MAPK/Erk Kinase
|
BRPI0614884A2
(pt)
|
2005-08-25 |
2011-04-19 |
Hoffmann La Roche |
inibidores de p38 map cinase e métodos para uso dos mesmos
|
WO2007025534A1
(de)
|
2005-09-01 |
2007-03-08 |
Bioagency Ag |
Fredericamycin-derivate
|
BRPI0616459A2
(pt)
|
2005-09-29 |
2011-06-21 |
Wyeth Corp |
compostos das fórmulas i, ii, e iii; processos para o tratamento ou para a prevenção de: um estado de saúde com melhora devido à recaptação de monoamina; pelo menos um sintoma vasomotor; pelo menos um distúrbio depressivo; pelo menos uma disfunção sexual; para a prevenção de dor; de distúrbio gastrointestinal ou genitourinário; de sìndrome de fadiga crÈnica; de sìndrome de fibromialgia; de esquizofrenia; e uso de um composto
|
SI1951724T1
(sl)
|
2005-11-17 |
2011-09-30 |
Osi Pharmaceuticals Llc |
Kondenzirani biciklični mTOR inhibitorji
|
EP1954276A2
(en)
*
|
2005-11-22 |
2008-08-13 |
Merck & Co., Inc. |
Indole orexin receptor antagonists
|
AR057960A1
(es)
*
|
2005-12-02 |
2007-12-26 |
Osi Pharm Inc |
Inhibidores de proteina quinasa biciclicos
|
JP2009520028A
(ja)
|
2005-12-19 |
2009-05-21 |
オーエスアイ・ファーマスーティカルズ・インコーポレーテッド |
Igfr抑制剤および抗癌剤の併用
|
EP1973917B1
(en)
*
|
2005-12-29 |
2015-06-10 |
AbbVie Inc. |
Protein kinase inhibitors
|
WO2007087395A2
(en)
|
2006-01-25 |
2007-08-02 |
Osi Pharmaceuticals, Inc. |
UNSATURATED mTOR INHIBITORS
|
WO2007089669A2
(en)
|
2006-01-26 |
2007-08-09 |
Wyeth |
Processes for the preparation of compounds which modulate cell proliferation
|
BRPI0708615A2
(pt)
|
2006-03-07 |
2011-06-07 |
Array Biopharma Inc |
compostos de pirazol heterobicìclicos e métodos de uso
|
US7651687B2
(en)
|
2006-03-13 |
2010-01-26 |
Osi Pharmaceuticals, Inc. |
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors
|
WO2007112005A2
(en)
|
2006-03-24 |
2007-10-04 |
Syntonix Pharmaceuticals, Inc. |
Pc5 as a factor ix propeptide processing enzyme
|
CN101460161A
(zh)
|
2006-03-29 |
2009-06-17 |
弗尔德里克斯制药股份有限公司 |
α-突触核蛋白毒性的抑制
|
US7585868B2
(en)
*
|
2006-04-04 |
2009-09-08 |
The Regents Of The University Of California |
Substituted pyrazolo[3,4-D]pyrimidines as kinase antagonists
|
WO2007121453A2
(en)
|
2006-04-17 |
2007-10-25 |
The Regents Of The University Of California |
2-hydroxy-1-oxo 1,2 dihydro isoquinoline chelating agents
|
GB0607948D0
(en)
*
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
GB0607950D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
PL2322525T3
(pl)
|
2006-04-21 |
2014-03-31 |
Novartis Ag |
Pochodne puryny do zastosowania jako agoniści receptora adenozyny A<sub>2A</sub>
|
EP2100004A4
(en)
|
2006-04-21 |
2015-10-21 |
Shell Int Research |
HIGH STRENGTH ALLOYS
|
US20090082370A1
(en)
|
2006-04-25 |
2009-03-26 |
Neil Thomas Thompson |
Pharmaceutical Combinations of PK Inhibitors and Other Active Agents
|
WO2007125315A2
(en)
|
2006-04-25 |
2007-11-08 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
DE102006020327A1
(de)
|
2006-04-27 |
2007-12-27 |
Bayer Healthcare Ag |
Heterocyclisch substituierte, anellierte Pyrazol-Derivate und ihre Verwendung
|
EP2029593A1
(en)
|
2006-05-22 |
2009-03-04 |
AstraZeneca AB |
Indole derivatives
|
US20080003254A1
(en)
*
|
2006-05-23 |
2008-01-03 |
Abbott Laboratories |
Systems and methods for delivering a rapamycin analog that do not inhibit human coronary artery endothelial cell migration
|
GB0610242D0
(en)
|
2006-05-23 |
2006-07-05 |
Novartis Ag |
Organic compounds
|
GB0610317D0
(en)
|
2006-05-24 |
2006-07-05 |
Medical Res Council |
Antiparasitic compounds and compositions
|
AU2007275682B2
(en)
*
|
2006-07-20 |
2012-05-17 |
Amgen Inc. |
Substituted pyridone compounds and methods of use
|
BRPI0714614A2
(pt)
|
2006-07-28 |
2013-05-14 |
Novartis Ag |
quinazolina 2,4-substituÍdas como inibidores de lipÍdeos cinase
|
JP2010500994A
(ja)
*
|
2006-08-16 |
2010-01-14 |
エグゼリクシス, インコーポレイテッド |
Pi3kおよびmekモジュレーターを使用する方法
|
US8541428B2
(en)
|
2006-08-22 |
2013-09-24 |
Technion Research And Development Foundation Ltd. |
Heterocyclic derivatives, pharmaceutical compositions and methods of use thereof
|
US7678803B2
(en)
|
2006-08-24 |
2010-03-16 |
Serenex, Inc. |
Quinazoline derivatives for the treatment of cancer
|
CA2974246C
(en)
|
2006-09-01 |
2020-02-25 |
Senhwa Biosciences, Inc. |
Tricyclic heteroaryl compounds and their use as protein modulators
|
WO2008025755A1
(de)
|
2006-09-01 |
2008-03-06 |
Basf Se |
Verwendung von n-haltigen heterozyklen in dermokosmetika
|
EP1903044A1
(en)
|
2006-09-14 |
2008-03-26 |
Novartis AG |
Adenosine Derivatives as A2A Receptor Agonists
|
EP1900729A1
(en)
|
2006-09-15 |
2008-03-19 |
Novartis AG |
Benzoxazoles and oxazolopyridines being useful as Janus kinases inhibitors
|
WO2008047821A1
(fr)
|
2006-10-18 |
2008-04-24 |
Takeda Pharmaceutical Company Limited |
Composé hétérocyclique fusionné
|
US7772180B2
(en)
|
2006-11-09 |
2010-08-10 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
WO2008064018A1
(en)
|
2006-11-13 |
2008-05-29 |
Eli Lilly & Co. |
Thienopyrimidinones for treatment of inflammatory disorders and cancers
|
WO2008063625A2
(en)
|
2006-11-20 |
2008-05-29 |
Adolor Corporation |
Pyridine compounds and methods of their use
|
CN101611007A
(zh)
|
2006-12-20 |
2009-12-23 |
先灵公司 |
新颖的jnk抑制剂
|
ES2385759T3
(es)
|
2006-12-22 |
2012-07-31 |
Industrial Research Limited |
Análogos azetidina de inhibidores de nucleosidasa y fosforilasa
|
WO2008083070A1
(en)
|
2006-12-29 |
2008-07-10 |
Neurogen Corporation |
Crf1 receptor ligands comprising fused bicyclic heteroaryl moieties
|
EP2124954A2
(en)
|
2007-01-26 |
2009-12-02 |
Irm Llc |
Purine compounds and compositions as kinase inhibitors for the treatment of plasmodium related diseases
|
WO2008112715A2
(en)
|
2007-03-12 |
2008-09-18 |
Vm Discovery Inc. |
Novel agents of calcium ion channel modulators
|
CA2680783C
(en)
|
2007-03-23 |
2012-04-24 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
JP5527761B2
(ja)
|
2007-03-23 |
2014-06-25 |
アムジエン・インコーポレーテツド |
複素環化合物およびそれの使用
|
ES2446417T3
(es)
|
2007-03-23 |
2014-03-07 |
Amgen Inc. |
Derivados de quinolina o quinoxalina sustituidos en 3 y su uso como inhibidores de fosfatidilinositol 3-cinasa (PI3K)
|
WO2008156513A2
(en)
|
2007-03-29 |
2008-12-24 |
University Of Connecticut |
Methods to protect skeletal muscle against injury
|
CN101657422A
(zh)
|
2007-04-13 |
2010-02-24 |
塞诺菲-安万特股份有限公司 |
过渡金属催化的n-氨基吲哚的合成
|
WO2008125014A1
(fr)
|
2007-04-13 |
2008-10-23 |
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. |
Composés d'urée, leurs procédés de préparation et leurs utilisations pharmaceutiques
|
JP2010163361A
(ja)
|
2007-04-27 |
2010-07-29 |
Dainippon Sumitomo Pharma Co Ltd |
キノリン誘導体
|
US7960353B2
(en)
|
2007-05-10 |
2011-06-14 |
University Of Kansas |
Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
|
WO2008147852A1
(en)
|
2007-05-22 |
2008-12-04 |
Taigen Biotechnology Co., Ltd. |
Kinesin inhibitors
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
US9603848B2
(en)
|
2007-06-08 |
2017-03-28 |
Senomyx, Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
WO2009000412A1
(en)
|
2007-06-26 |
2008-12-31 |
Sanofi Aventis |
A regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles
|
WO2009004621A1
(en)
|
2007-07-02 |
2009-01-08 |
Technion Research & Development Foundation Ltd. |
Compositions, articles and methods comprising tspo ligands for preventing or reducing tobacco-associated damage
|
RU2345996C1
(ru)
|
2007-07-17 |
2009-02-10 |
Андрей Александрович Иващенко |
Аннелированные азагетероциклические амиды, включающие пиримидиновый фрагмент, способ их получения и применения
|
EP2190466A4
(en)
*
|
2007-08-10 |
2011-12-21 |
Burnham Inst Medical Research |
Tissue-specific alkaline phosphatase (TNAP) activators and their use
|
EP2185570B1
(en)
|
2007-08-13 |
2014-03-19 |
Metabasis Therapeutics, Inc. |
Novel activators of glucokinase
|
CN101835776A
(zh)
|
2007-08-14 |
2010-09-15 |
拜耳先灵医药股份有限公司 |
用于癌症治疗的稠合的咪唑
|
JP5227965B2
(ja)
|
2007-10-03 |
2013-07-03 |
独立行政法人理化学研究所 |
ニトロトリアゾール誘導体、およびそれを用いる化合物の製造方法
|
US20110160232A1
(en)
|
2007-10-04 |
2011-06-30 |
Pingda Ren |
Certain chemical entities and therapeutic uses thereof
|
KR20100089082A
(ko)
|
2007-10-15 |
2010-08-11 |
아스트라제네카 아베 |
조합 059
|
JP2009104221A
(ja)
*
|
2007-10-19 |
2009-05-14 |
Fujitsu Ltd |
情報システム
|
US20110218210A1
(en)
|
2007-11-02 |
2011-09-08 |
Taiga Biotechnologies |
Compounds for treating abnormal cellular proliferation
|
EP2220089A4
(en)
|
2007-11-13 |
2011-10-26 |
Icos Corp |
HEMMER OF HUMAN PHOSPHATIDYL-INOSITOL 3-KINASE-DELTA
|
CA2708391A1
(en)
|
2007-12-13 |
2009-06-25 |
Sri International |
Ppar-delta ligands and methods of their use
|
US7960397B2
(en)
|
2007-12-28 |
2011-06-14 |
Institute Of Experimental Botany, Academy Of Sciences Of The Czech Republic |
6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
WO2009088990A1
(en)
*
|
2008-01-04 |
2009-07-16 |
Intellikine, Inc. |
Certain chemical entities, compositions and methods
|
EP2240020A4
(en)
|
2008-01-09 |
2011-05-11 |
Trovis Pharmaceuticals Llc |
INTRATHEAL TREATMENT OF NEUROPATHIC PAIN WITH A2AR AGONISTS
|
US20110098267A1
(en)
|
2008-02-07 |
2011-04-28 |
Synta Pharmaceuticals Corporation |
Topical formulations for the treatment of psoriasis
|
US20090203689A1
(en)
|
2008-02-07 |
2009-08-13 |
Arvinder Dhalla |
Abca-1 elevating compounds and methods
|
TWI444384B
(zh)
|
2008-02-20 |
2014-07-11 |
Gilead Sciences Inc |
核苷酸類似物及其在治療惡性腫瘤上的用途
|
US8637542B2
(en)
*
|
2008-03-14 |
2014-01-28 |
Intellikine, Inc. |
Kinase inhibitors and methods of use
|
WO2009114874A2
(en)
|
2008-03-14 |
2009-09-17 |
Intellikine, Inc. |
Benzothiazole kinase inhibitors and methods of use
|
EP2288611B1
(en)
|
2008-03-20 |
2013-05-15 |
Amgen Inc. |
Aurora kinase modulators and method of use
|
US20090312406A1
(en)
|
2008-06-12 |
2009-12-17 |
Hsing-Pang Hsieh |
Coumarin compounds and their use for treating viral infection
|
WO2010006072A2
(en)
|
2008-07-08 |
2010-01-14 |
The Regents Of The University Of California |
Mtor modulators and uses thereof
|
CN102124009B
(zh)
|
2008-07-08 |
2014-07-23 |
因特利凯公司 |
激酶抑制剂及其使用方法
|
JP2011528368A
(ja)
|
2008-07-16 |
2011-11-17 |
シェーリング コーポレイション |
二環式ヘテロ環誘導体およびgpcrモジュレーターとしてのその使用
|
US8450344B2
(en)
|
2008-07-25 |
2013-05-28 |
Aerie Pharmaceuticals, Inc. |
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
|
JP2011530596A
(ja)
|
2008-08-11 |
2011-12-22 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
tRNA合成酵素の阻害のためのハロフジノン類似体およびそれらの使用
|
AU2009298877A1
(en)
|
2008-09-23 |
2010-04-08 |
Georgetown University |
Viral and fungal inhibitors
|
WO2010036380A1
(en)
|
2008-09-26 |
2010-04-01 |
Intellikine, Inc. |
Heterocyclic kinase inhibitors
|
US8476282B2
(en)
*
|
2008-11-03 |
2013-07-02 |
Intellikine Llc |
Benzoxazole kinase inhibitors and methods of use
|
EP2391627B1
(en)
|
2009-01-28 |
2013-12-25 |
Cara Therapeutics, Inc. |
Bicyclic pyrazolo-heterocycles
|
US20120189641A1
(en)
|
2009-02-25 |
2012-07-26 |
OSI Pharmaceuticals, LLC |
Combination anti-cancer therapy
|
WO2010118367A2
(en)
|
2009-04-10 |
2010-10-14 |
Progenics Pharmaceuticals, Inc. |
Antiviral pyrimidines
|
WO2010129816A2
(en)
|
2009-05-07 |
2010-11-11 |
Intellikine, Inc. |
Heterocyclic compounds and uses thereof
|
CN101602768B
(zh)
|
2009-07-17 |
2012-05-30 |
河南省农科院农副产品加工研究所 |
一种芝麻素和芝麻林素的提纯方法
|
AR085397A1
(es)
|
2011-02-23 |
2013-09-25 |
Intellikine Inc |
Combinacion de inhibidores de quinasa y sus usos
|